Cargando…
Recovery fulminant hepatitis A in systemic juvenile idiopathic arthritis patient treated with tocilizumab: a case report
INTRODUCTION: Systemic juvenile idiopathic arthritis (sJIA) is a rare systemic immune disorder that affects patients before 16 years of age. Several viruses have been reported to trigger this disease. Increased use of biologics, such as tocilizumab and anakinra, and decreased use of glucocorticoid m...
Autores principales: | Kudsi, Maysoun, Alghawe, Fatima, Hamsho, Suaad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553018/ https://www.ncbi.nlm.nih.gov/pubmed/37811054 http://dx.doi.org/10.1097/MS9.0000000000001154 |
Ejemplares similares
-
Tocilizumab in the treatment of systemic juvenile idiopathic arthritis
por: Murakami, Miho, et al.
Publicado: (2012) -
Tocilizumab in systemic sclerosis treatment: a case report
por: Kudsi, Maysoun, et al.
Publicado: (2023) -
Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab
por: De Benedetti, Fabrizio, et al.
Publicado: (2014) -
A case report of sarcoidosis overlapped with Sjogren’s syndrome
por: Kudsi, Maysoun, et al.
Publicado: (2023) -
Tocilizumab-effects on growth impairment in systemic juvenile idiopathic arthritis
por: Miyamae, Takako, et al.
Publicado: (2011)